Sign In to Follow Application
View All Documents & Correspondence

Synthesis And Application Of A Novel Antimicrobial Active

Abstract: ABSTRACT The disclosure Synthesis & Application of a Novel Antimicrobial active provides a method of synthesis of organic complex starting from saturated fatty acid with a free base bioactive molecule containing nitrogen atoms. The reaction is usually conducted in refluxing alcohol. The product is synthesized by a acid-base reaction whereby the acid molecule is capable of donating a proton, to the free base molecule resulting in the formation of the desired complex. These complexes are very effective antimicrobial active against a variety of bacteria, fungi, protoZoa, helminthes and viruses. Individually, the antimicrobial actives of this invention are well known in the published literature, however the complexes of this invention are quite unique, novel and represent new antimicrobial compositions; their isolation and characterization and precise usage in the formulations. The process is suitable for large-scale synthesis and involves simple and high-yielding techno feasible chemical transformations using low-cost commercially available raw materials. The complex has wide spread use in human personal care, industries and household applications , as the disclosed chemical has antimicrobial activity against gram positive, gram negative bacteria , yeast, mold, fungi.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
12 February 2016
Publication Number
33/2017
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
ashpk50@gmail.com
Parent Application
Patent Number
Legal Status
Grant Date
2019-11-21
Renewal Date

Applicants

Salicylates & Chemical Pvt. Ltd.
5/44, Tardeo Airconditioned Market, Mumbai - 400 034,

Inventors

1. Samir Sarvaiya,
5/44, Tardeo Airconditioned Market, Mumbai - 400 034,
2. K. Rakesh Ratnam
5/44, Tardeo Airconditioned Market, Mumbai - 400 034,

Specification

DESC:The following specification particularly describes the invention and the manner in which it is to be performed
Present invention discloses Synthesis and Application of a Novel Antimicrobial active
Particularly the invention provides an organic amino- salt ingredient as an efficient antimicrobial agent for personal care, oral care; home care and topical pharmaceutical formulation.

Antimicrobial ingredients are materials that protect against the growth of microorganisms in personal care products, including bacteria, viruses and fungi. Antimicrobial personal care products, which are sometimes referred to as antibacterial products, provide an important extra measure of protection for consumers at home and doctors and nurses in hospitals seeking to prevent spread of germs. These products, depending on their formulation and application, kill or inhibit the growth of bacteria that cause skin infections, intestinal illnesses or other commonly transmitted diseases. These include potentially fatal illnesses caused by bacteria such as Salmonella and E.coli.

Antimicrobial ingredients play an important role in making sure that personal care products are free of microorganisms during storage and after they are opened. They are effective at low levels so that it doesn’t take much of the ingredient to work. There are many different types of materials that can be used in products and they are selected based on the specific type of product. A water-based product may use a different type of ingredient (or combination of ingredients) than an oil-based product. The same ingredients that are used to protect cosmetic product integrity may also be used in OTC Antimicrobial drug products, although the amount added may be different.

Anti microbial protection and the related biotechnologies are more relevant today than ever before.

Chlorhexidine and its salts are reported as being used in cosmetics as an active ingredient to give the desired effect or as a preservative in concentrations of 0.1% to 0.3 %. Such products include mouthwashes, hair dying and bleaching formulations, shampoos, anti hair “aging” products and exfoliants, body lotions, eye creams, face cleansers, sun cream, after-sun lotions, eye makeup removers, and facial masks.
Within the health sector, chlorhexidine is used in formulations for preoperative skin disinfection, in treatment of wounds and burns, for urinary bladder flushing, for catheter disinfection, and in ophthalmology and gynecology. In cosmetic products, chlorhexidine is commonly used in combination with other agents with antimicrobial activity in order to improve the biocidal effect.

European patent application No EP0807440A2 teaches synthesis of aqueous Chlorhexidine gluconate-containing stabilized aqueous pharmaceutical preparations. The disclosure essentially teaches use of the chemical for eye care and nasal care. It further teaches use of preparation further contains at least one pharmaceutical^ acceptable polycarboxylic acid.
Chlorhexidine gluconate, a salt of chlorhexidine with gluconic acid and salts of chlorhexidine base with other organic and inorganic acid, are used as local disinfectants for disinfection of fingers and skin, and disinfection of the site of surgery, disinfection of surgical tools and in the areas of personal care. Chlorhexidine gluconate and other acid salts are also widely used as a preservative to prevent growth of microorganisms in cosmoceuticals and pharmaceutical preparations for external use and preparations for topical use such as, eye drops and nasal drops.

A US patent publication No2004/0234496A1 on the other hand, teaches a biocidal compositions formed by metathesis of either mono meric or polymeric bioactive cations with either monomeric or polymeric bioactive anions to from an essentially water insoluble complexes.

The salts of chlorhexidine base with the organic acids have been reported earlier. Some references are there for chlorohexidene base and the saturated fatty acids of the base.
Fatty acids are known to possess antibacterial, antimalarial and antifungal activity. Fatty acids pose less environmental risks. They are not only biodegradable, but exhibit a high degree of specificity. In addition, fatty acids are accepted food additives and importantly, pathogenic fungi are less likely to become resistant to antifungal fatty acids. The most important target of antifungal fatty acids is the cell membrane. They cause an increase in membrane fluidity, which will result in leakage of the intracellular components and cell death.

Unsaturated fatty acids contain fixed bend C=C bonds and will therefore occupy a greater cross section when inserted into the membrane as disclosed in Applied and Environmental Microbiology. 2001;67:956-960. They are proposed to have increased fungicidal activity due to their increased motional freedom inside the membrane. It must however be noted that increased oxidative stress caused by incorporation of polyunsaturated lipids in the membrane, may contribute to the antifungal activity of these fatty acids as disclosed in Marine Drugs. 2010;8:2597-2604
Undecylenic acid (C11) or also called 10-undecenoic acid is an organic unsaturated fatty acid derived from castor oil by cracking. Undecylenic acid is an FDA approved active ingredient in medications for skin infections, and relieves itching, burning, and irritation. In technical applications it is used because of its antifungal properties. Undecenoic acid is known to inhibit growth of the Myrothecium verrucaria as disclosed in American Oil Chemists’ Society; 1978:51-62. , Saccharomyces cerevisiae as discloaed in Biochimica et Biophysica Acta. 2002;1581:109-118.
For last four decades TRICLOSAN has been synonymous with the personal care & product based hygienic Industry, enduring successfully a time-tested path for its activity as well as safety. The twin driving forces apart from creating a unique anti microbial also have paved ways into cutting edge markets catering not just to curative but also to prophylactic and preventive segments. The chemical, triclosan, is a synthetic, broad-spectrum antimicrobial agent that in recent years has exploded onto the consumer market in a wide variety of antibacterial soaps, deodorants, toothpastes, cosmetics, fabrics, plastics, and other products.

However; recently many studies have increasingly linked triclosan to a range of health and environmental effects, from skin irritation, allergy susceptibility, bacterial and compounded antibiotic resistant, and dioxin contamination to destruction of fragile aquatic ecosystems.. According to the American Medical Association, “Despite their recent proliferation in consumer products, the use of antimicrobial agents such as triclosan in consumer products has not been studied extensively. No data exist to support their efficacy when used in such products or any need for them…it may be prudent to avoid the use of antimicrobial agents in consumer products…”2(Ref 5 American Medical Association. 2000. Use of Antimicrobials in Consumer Products. Report 2 of the Council on Scientific Affairs (A-00).The other drawback of triclosan is that it is not biodegradable.

Consumers are concerned about the recent studies that have prompted further FDA and EPA review of Triclosan. For formulators seeking Triclosan alternatives, there is a need to provide a suitable replacement with similar efficacy.
U.S. Patent (No. 2,684,924 ) describes the preparation of the dihydrochloride, digluconate and diacetate salts of chlorhexidine base. All the three salts are derived by either using an inorganic acid or a small molecular weight organic acid. Higher molecular saturated acid also have been reported to form salt with the chlorhexidene base. Some are reported in Pat: EP0707794A1 wherein salt with acetic lactic acid, malic acid, salicylic acid, and palmitic lactic acid are described. Some of the salts are presumed to be made insitu with appropriate ratios of the ingredient in a desired solvent and used as such for the antimicrobial application.
There is need for a broad spectrum, biodegradable microbial agent which will work across for the control of gm+ve, gm –ve bacteria, yeast mold and fungi

Principal objective of the present invention is to provide synthesis of chlorhexidine based organic complex and its application as an efficient antimicrobial active for various industrial, cosmaceutical, and pharmaceutical formulations. .
Another objective of the invention is to provide the active antimicrobial ingredient to be used in the preparation of personal care formulations.
Another objective of the invention is to provide the active antimicrobial ingredient to be used in the preparation of industrial substances such as Plastic,Textiles and Polymers .
Another objective of the invention is to provide the active antimicrobial ingredient to be used in the preparation of oral care preparations such as toothpaste and mouthwash rinses.
Another objective is to isolate and characterize the novel antimicrobial active
Another objective is to show the efficacy of the novel antimicrobial active in cosmeceutical skin car, hair care formulation, oral care cosmeceutical and pharmaceutical formulation and pharmaceutical topical formulation.
Another objective is to show the efficacy of the novel antimicrobial active as a disinfectant in home care and pharmaceutical formulation.
Another objective is to show the efficacy of the antimicrobial active for its application in the soaps and detergents including the dish washing detergents.
An embodiment of the complex is shown in the figure 1

According to the main aspect of the invention there is provided synthesis of chlorhexidine based organic complex which comprises the steps of :
heating up slowly the mixture of rectified spirit and fatty acid having with Cn in a temperature range of 20 to 50 o to get a clear solution,
clear solution further being maintained under stirring for homogenization leading to complete solid precipitation and the mass cooled further to room temperature ,
solid precipitate being then filtered suck dry, to collect wet cake,
the solid wet cake then dissolved in alcoholic or alkyl ,aryl solvent, ketonic solvent,
the solution is heated to a temperature range of 40 to 80 degress preferably between 40 to 60 degrees and most preferable temperature 45 –500C,
the solution of wet cake in acetone charged with activated charcoal and heating up to reflux,
collecting mother liquor slowly and cooling down to room temp and chilled to about 4 to 6 degree for complete precipitation of the product,
the wet cake after filtration was washed with chilled solvent preferably acetone, squeeze out main mother liquor and collecting the wet cake followed by drying to get chlorhexidine based organic complex.
According to another aspect of the invention wherein, preferred fatty acid is undecylenic acid.
According to a further aspect of the invention wherein alcoholic or alkyl ,aryl solvent are selected from a group of methanol, isopropanol or any low boiling alcoholic solvent.
According to a further aspect of the invention wherein, ketonic solvent is selected from a group of methyl ethyl ketone, acteophenone , acetone, preferably low boiling alkyl ketones.
According to a still further aspect of the invention wherein, organic complex has negligible oral toxicity.
According to a yet another aspect of the invention wherein, organic complex has negligible dermal toxicity .
According to a still another aspect of the invention wherein, organic complex has antimicrobial efficacy for the hand wash.
According to a still another aspect of the invention wherein the organic complex is useful in oral health, dental care.
According to still another aspect of the invention wherein, the organic complex is useful in hair care, skin care formulations.
According to still another aspect of the invention wherein, hair care formulations comprise, hair oil, hair creams shampoo, antidandruff applications.
According to still another aspect of the invention wherein, , skin care formulations comprise powders, sun screens, lotions, lipsticks and the like.
According to still another aspect of the invention wherein, the organic complex is used in disinfectants in pharmaceutical disinfectant for instruments, hand washes.
According to one aspect of the invention wherein, the organic complex is used as antifungal and antifouling agent in Paints , coatings.
According to one more aspect of the invention wherein, the organic complex has antimicrobial activity against gram positive, gram negative bacteria , yeast, mold, fungi.
This present disclosure describes the technique of the preparation of the acid salt of the chlorhexidine base. Chlorhexidine is a guanidine derivative which has a potential to form a salt with one or more moles of acid per mole of the base. The technique in making the desired product depends on the various factors like the mole ratio of the raw materials, temperature, selection of the reaction medium and reaction time.
The base materials used in the present invention are as given in table-1 below
Table -1
S.NO RAW MATERIALS M W QUANTITY MOLES S/R
1 Rectified spirit 46 500g 10.86 54.84
2 Undecylenic acid 184.28 75g 0.406 2.05
3 CH Base 505.45 100g 0.197 1.0
4 Activated Charcoal - 5.0 g - -
5 Hiflow (super cell) - 25g - -
6 Acetone 58.0 400 ml 6.9 34.8

Following examples are given for illustration and do not limit the scope of invention
Example 1
Synthesis of chlorhexidine based organic complex is achieved by first charging 500g of rectified spirit at room temperature. To this 75 g undecylenic acid is added under stirring. This reaction mixture is then heated up slowly to 40oC to get a clear solution. Then Chlorohexedine base is charged lot wise within 1 hr under controlled temp parameter. The reaction mass is maintained at 400 C for 2hrs during which a solid precipitation is obtained . The reaction mass was further maintained for 1hr to effect completing precipitation of product and cooled to room temperature. Solid precipitated is then filtered and suck dried to collect the wet cake. The solid wet cake then dissolved in alcoholic solvent, To purify the wet cake, the solid wet cake was then dissolved in acetone and heated to 45 –500 C . To this solution was charged 5g activated charcoal and heated up to reflux for 30 mins and filtered over super cell bed to get a clear colorless solution. Finally, the clear colorless filtrate was cooled down to room temperature first and chilled up to 5-6oC over a period of couple of hours. The product was filtered to get the wet cake. The wet cake was washed with 50 X 2 chilled acetone and suck dried. Finally, crystallized cake is dried by VTD for 4- 5hrs to get 55g chlorhexidine undecylinate..

Example – 2
Synthesis of chlorhexidine based organic complex is achieved by first charging 500g of rectified spirit at room temperature. To this 75 g undecylenic acid is added under stirring. This reaction mixture is then heated up slowly to 400C to get a clear solution. Then Chlorohexedine base is charged lot wise within 1 hr under controlled temp parameter. The reaction mass is maintained at 400 C for 2hrs during which a solid precipitation is obtained . The reaction mass was further maintained for 1hr to effect completing precipitation of product and cooled to room temperature. Solid precipitated is then filtered and suck dried to collect the wet cake. The solid wet cake then dissolved in an aryl solvent. To purify the wet cake, the solid wet cake was then dissolved in acetone and heated to 45 0C To this solution was charged 5g activated charcoal and heated up to reflux for 30 mins and filtered over super cell bed to get a clear colorless solution. Finally, the clear colorless filtrate was cooled down to room temperature first and chilled up to 5-6oC over a period of couple of hours. The product was filtered to get the wet cake. The wet cake was washed with 50 X 2 chilled acetone and suck dried. Finally, crystallized cake is dried by VTD for 4- 5hrs to get 55g chlorhexidine undecylinate.
Example -3
Synthesis of chlorhexidine based organic complex is achieved by first charging 500g of rectified spirit at room temperature. To this 75 g undecylenic acid is added under stirring. This reaction mixture is then heated up slowly to 400C to get a clear solution. Then Chlorohexedine base is charged lot wise within 1 hr under controlled temp parameter. The reaction mass is maintained at 400 C for 2hrs during which a solid precipitation is obtained . The reaction mass was further maintained for 1hr to effect completing precipitation of product and cooled to room temperature. Solid precipitated is then filtered and suck dried to collect the wet cake. The solid wet cake then dissolved in a ketonic solvent. To purify the wet cake, the solid wet cake was then dissolved in acetone and heated to 45 0C To this solution was charged 5g activated charcoal and heated up to reflux for 30 mins and filtered over super cell bed to get a clear colorless solution. Finally, the clear colorless filtrate was cooled down to room temperature first and chilled up to 5-6oC over a period of couple of hours. The product was filtered to get the wet cake. The wet cake was washed with 50 X 2 chilled acetone and suck dried. Finally, crystallized cake is dried by VTD for 4- 5hrs to get 55g chlorhexidine undecylinate.

The above produced product is analyzed by using the following HPLC method.
HPLC Column
Column :
The liquid chromatograph is equipped with a 239¬nm detector and a 4.6¬mm × 25¬cm column that contains base¬ deactivated 5¬µm packing L1.
Column Temperature : About 40 .
Flow rate : About 1.5 mL per minute.
Chromatograph the System suitability solution, and record the peak responses as directed for Procedure: the resolution, R, between chlorhexidine and p¬chloroaniline is not less than 3; and the relative standard deviation for replicate injections is not more than 2% determined from the chlorhexidine peak and not more than 5% determined from the p¬chloroaniline peak. Procedure— Separately inject equal volumes (about 50 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the peak areas for chlorhexidine. Calculate the percentage (w/v) of C22H30Cl2N10·2C6H12O7 in the portion of Solution taken by the formula: (897.77/625.66)(0.25C)(rU / rS ), in which 897.77 and 625.66 are the molecular weights of chlorhexidine gluconate and chlorhexidine acetate, respectively; C is the concentration, in µg per mL, of USP Chlorhexidine Acetate RS in the Standard preparation; and rU and rS are the peak areas for chlorhexidine obtained from the Assay preparation and the Standard preparation, respectively
NMR Spectral analysis.
1H NMR (400 MHz, DMSO-d6) d (ppm): 0.89-0.97(d, 4 x 3H), 1.3-1.7 (m, 20H), 1.38-1.41 (t, 3H), 2.58-2.6(m, 2H), 3.08-3.1(m, 4H), 3.48 (s, 2H), 4.07-4.12(q, 2H), 5.37-5.38(m, IH), 5.5-5.57 (m, IH), 6.8-7.6 (m, 8H), 6.8-7.6 (d, 3H), 8.32-8.34(d, IH), 8.41-8.44(d, IH); and
MS: m/z : 873.
Applications of the chlorhexidine base complex are described below
In order to substantiate the efficacy of the complex was subjected to kill test of on Oral Care Bacteria. This test is essential to be able to be used in oral care like toothpaste and hand wash care.
Time Kill Test by ASTM E 2315 03 (Re 2008
Test Inoculum used is :
1. Escherichia coli ATCC 11229
2. Staphylococcus aureus ATCC 6538
3. Pseudomonas aeruginosa ATCC 10145
4. Streptococcus mutans ATCC 25175
5. Enterococcus faecalis ATCC 29212
6. Candida albicans ATCC 10231
7. Candida tropicalis ATCC 13803
Test Conditions:
Test Product : Hand Wash as it is
Contact Time : 30 seconds, 60 seconds and 2 minutes
Contact Temperature : Room Temperature
Diluent / Neutraliser : Lecithin, Polysorbate 80, Sod. Thiosulphate, Histidine, Saponin in
Phosphate buffer 0.0025 mol/l
Media and Reagent : Soyabeancasein digest agar for bacteria
Incubation condition : 370 C
Procedure:
Test product was inoculated with test organisms individually (approximately 108 CFU/ ml). After the specified exposure time of 30 seconds, 60 seconds & 2 minutes surviving microorganisms were recovered by drawing an aliquot, neutralizing it and performing Standard Pour plate Technique. Culture count was ascertained by dilution Blank. Adequate Validation of Neutralizing agent was also carried with both the test bacteria. Test was carried out in duplicate and average count was taken as CFU/ ml.
Table - 2
Test product hand wash with 0.1% CHUA
Test Organism Exposure Time Initial Count CFU/ml After exposure Log reduction Percentage reduction
CFU/ml Log
Esch.Coli 30 secs 3.5x106
Log=5.53 <10 <1 >4.53 >99.999
60 secs <10 <1 >4.53 >99.999
2 mins <10 <1 >4.53 >99.999
Staph aureus 30 secs 1.93x105
Log=5.28 <10 <1 >4.28 >99.999
60 secs <10 <1 >4.28 >99.999
2 mins <10 <1 >4.28 >99.999
Pseudo.aeruginosa 30 secs 1.80 x105
Log=5.25 <10 <1 >4.25 >99.999
60 secs <10 <1 >4.25 >99.999
2 mins <10 <1 >4.25 >99.999
Strepto.mutans 30 secs 1.78x105
Log=5.25 <10 <1 >4.25 >99.999
60 secs <10 <1 >4.25 >99.999
2 mins <10 <1 >4.22 >99.999
Entero.faecalis 30 secs 1.27x105
Log=5.10 <10 <1 >4.10 >99.999
60 secs <10 <1 >4.10 >99.999
2 min <10 <1 >4.10 >99.999
Can.albicans 30 secs 4.80x104
Log =4.68 <10 <1 >3.68 >99.99
60 secs <10 <1 >3.68 >99.99
2 min <10 <1 >3.68 >99.99
Can.Tropicalis 30 Secs 2.10x105
Log=5.32 <10 <1 >4.32 >99.999
60 Secs <10 <1 >4.32 >99.999
2 min <10 <1 >4.32 >99.999
Following Formulae was used in computing test results:
Percentage Reduction of Microorganism = 100 (Initial – After Exposure)/ Initial
Log Reduction = Log Initial – Log after Exposure
Handwash with 0.1% CHUA has shown >99.999% reduction of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa,
Streptococcus mutans, Enterococcus faecalis, Candida albicans and Candida tropicalis in 30 seconds when analysed as per ASTM E 2315 – 03 (Re. 2008) Method

Hand wash formulation using the chlorhexidine base complex
Table 3
Hand Wash using CHUA
Sr.No. Ingredients INCI Name Formula 1 % Function
1 Water Aqua 63.4 Solvent
2 surfactant a nonionic or a combination of non ionic and anionic surfactant 25 Surfactant
3 CAPB Coco amidopropyl betain 7 Surfactant
4 Polyquate 7 Polyquaternium 7 0.5 Moisturizing
5 Disodium EDTA Disodium EDTA 0.1 Chelating agent
6 Sodium benzoate Sodium benzoate 0.5 Preservative
7 Propylene Glycol Propylene Glycol 3 Humectant/Solvent
8 CHUA Chlorhexidine Undecylenate 0.1 Anti microbial
9 NaCl (Salt) Sodium Chloride QS Thickener
10 Perfume Perfume 0.2 Perfume
11 Citric Acid Citric acid QS pH adjuster
pH of product pH-5.4

A general preferred process but without limiting the scope of the invention is Add ingredients from (1) to (6) in one vessel add one by one. Slowly stirring the system.
Premix Propylene Glycol & Anti microbial agent (CHUA) and add it into system and stir it. Then added the desired perfume, followed by addition of salt to the system to get the desired viscocity Stir the content and check the pH & if the desired pH is not attained add Citric acid to adjust the pH.. The product was tested for stability and it was found to be stable at 450C for a minimum of one month.
The efficacy of the disclosed CHUA molecule in had wash was compared with an Triclosan an antibacterial used widely in the market in the personal care and pharma formulation . The comparison as shown in Table -5

Table-4

Hand Wash with Triclosan
Sr.No. Ingredients INCI Name Formula 2 Function
1 Water Aqua 63.6 Solvent
2 surfactant SLES 25 Surfactant
3 CAPB Coco amidopropyl betain 7 Surfactant
4 Polyquate 7 Polyquaternium 7 0.5 Moisturizing
5 Disodium EDTA Disodium EDTA 0.1 Chelating agent
6 Sodium benzoate Sodium benzoate 0.5 Preservative
7 Propylene Glycol Propylene Glycol 3 Humectant/Solvent
8 Salisan Triclosan 0.3 Anti microbial
9 NaCl (Salt) Sodium Chloride QS Thickener
10 Perfume Perfume 0.2 Perfume
11 Citric Acid Citric acid QS pH adjuster
pH of product pH-6.1

Kill test were performed by both these formulation on both gram –ve and gram +ve bacterial.
Results of comparison between CHUA and Triclosan are shown in Table -5 .The tests were performed as per Manual of Microbiology Methods

Table – 5

Test Product Test Organism Exposure Time Anti Microbial Activity % reduction
0.3% Salisan (Triclosan)
Esch. Coli 30 Secs. 99.97
60 Secs. >99.99
2 Min. >99.99

Staph. Aureus 30 Secs. >99.99
60 Secs. >99.99
2 Min. >99.99
0.1% CHUA
(Chlorhexidine Undecylenate)
Esch. Coli 30 Secs. >99.99
60 Secs. >99.99
2 Min. >99.99

Staph. Aureus 30 Secs. >99.99
60 Secs. >99.99
2 Min. >99.99

By above test result shows 0.1% Chlorhexidine Undecylenate is more effectively working against microorganisms as compared to a higher required concentration of 0.3% Triclosan
The efficacy of the CHUA ingredient as an efficient and effective antimicrobial agent for both pharma and personal/oral care formulations have also been established .
Handwash with 0.1% Salibact and Handwash with 0.2% Salibact have shown >99.999%
reduction of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus mutans, Enterococcus faecalis, Candida albicans and Candida tropicalis in 30 seconds when analysed as per ASTM E 2315 – 03 (Re. 2008) Method The initial studies and observation reveals that this ingredient is effective against both gm+ve,gram –ve ,yeast, molds and oral care bacteria and is also active against the protozoan and helminthes.
CHUA of the present disclosure been used in oral care formulations as well as topical formulations like skin care and hair care. Some of the formulation made for the stability, efficacy and compatibility are shown as below.

Roll– on Deo with CHUA Formulation:
Phases Ingredients INCI Name Percentage Functions

A Eumulgin B2 Ceteareth20 2.5 Emulsifier
GMS SE
Glycero Monostearate 1
Emulsifier/Emollient
Cetostearyl Alcohol Cetostearyl Alcohol 15 Emulsion stabilizer
Xiameter PMX0245 Cyclopentasiloxane 3 Emollient
Montanov L C1422 Alcohols (and) C1220 Alkyl Glucoside 2 Emulsifier
B Water Aqua Upto 100 Solvent
C Propylene Glycol Propylene Glycol 3 Humectent
Salibact (CHUA) - 0.1 AntiBacterial
D Saliguard EHGP Ethylhexylglycerin(and)
Phenoxy ethanol 0.8 Preservative
Perfume Fragrance 0.4 Fragrance

Procedure to prepare the Deodorant with CHUA :
1) Add Phase A ingredients in one vessel one by one, heat it up to 800 C.
2) Heat Phase B vessel up to 800 C.
3) Add phase A into Phase B at same temperature (around 800 C) and stir both phase till the emulsion gets complete.
4) At the time of stirring add premix phase C.
5) When emulsion of temperature comes at room temperature add Phase D and give final Stirring to the product.pH6.0

Formulation for Toothpaste Chalk base with CHUA
S.No Ingredients INCI name Percentage Functions
1 Carrageenan Gum Carrageenan Gum 0.6 Binding Agent
2 Sorbitol 70% soln. Sorbitol 17 Humectant
3 Glycerin Glycerin 10 Humectant
4 Water Water Upto 100 Solvent
5 Sodium Benzoate Sodium Benzoate 0.3 Preservative
6 Sodium Saccharin Sodium Saccharin 0.2 Sweetner
7 Flavour Flavour 1 Flavour
8 Calcium carbonateIP/BP Calcium carbonate 46 Polishing Agent
9 CAPB Cocoamidopropyl
Betaine 5 Surfactant
10 Propylene Glycol Propylene Glycol 3 Humectant
11 CHUA _ 0.1 Anti Bacterial
Procedure steps to prepare toothpaste cahlk based powder:
1) Disperse Carrgeenan gum in glycerin.
2) Add Sorbitol and water and mix.
3) Disperse Sodium Saccharin and Sodium Benzoate in above solution.
4) Add abrasive Calcium carbonate and mix.
5) Add Flavour, mix and deaerate.
6) Add Cocoamidopropyl betaine and mix, and then add premix CHUA and Propylene glycol.
7) Give final mixing to the product under

Formulation for Toothpaste Gel with CHUA

S.No Ingredients INCI name Percentage Functions
1 Carrageenan gum Carrageenan gum 0.45 Binding Agent
2 Sorbitol 70%
Soln. Sorbitol 67 Humectant
3 Water Water Upto 100 Solvent
4 Sodium Benzoate Sodium Benzoate 0.5 Preservative
5 Sodium Saccharin Sodium Saccharin 0.2 Sweetener
6 Absil 100 Hydrated Silica 11 Polishing Agent
7 MfilP Hydrated Silica 7 Polishing Agent
8 Flavour Flavour 1 Flavour
9 CAPB Cocoamidoproplbetaine 5 Surfactant
10 Propylene Glycol Propylene Glycol 3 Humectant
11 CHUA - 0.1 Anti bacterial
12 Colour 1% Soln. Colour 0.02 Colour

Procedure:
1) Disperse Carrageenan gum in Sorbitol
2) Add water and mix.
3) Disperse Sodium benzoate and Sodium Saccharin in above solution.
4) Add abrasives Hydrated Silica, disperse and mix
5) Add flavor, mix and deaerate.
6) Add Cocoamidopropyl betaine and mix, and then add premix Salibact and Propylene
Glycol.
Mixing is done under vacuum.
,CLAIMS:1. Synthesis of chlorhexidine based organic complex which comprises the steps of :
heating up slowly the mixture of rectified spirit and fatty acid having with Cn in a temperature range of 20 to 50 o to get a clear solution,
clear solution further being maintained under stirring for homogenization leading to complete solid precipitation and the mass cooled further to room temperature ,
solid precipitate being then filtered suck dry, to collect wet cake,
the solid wet cake then dissolved in alcoholic or alkyl ,aryl solvent, ketonic solvent,
the solution is heated to a temperature range of 40 to 80 degress preferably between 40 to 60 degrees and most preferable temperature 45 –500C,
the solution of wet cake in acetone charged with activated charcoal and heating up to reflux,
collecting mother liquor slowly and cooling down to room temp and chilled to about 4 to 6 degree for complete precipitation of the product,
the wet cake after filtration was washed with chilled solvent preferably acetone,
squeeze out main mother liquor and collecting the wet cake followed by drying to get chlorhexidine based organic complex.
2. Chlorhexidine based organic complex of claim 1 wherein , preferred fatty acid is undecylenic acid.
3. Chlorhexidine based organic complex of claim 1 wherein alcoholic or alkyl ,aryl solvent are selected from a group of methanol, isopropanol or any low boiling alcoholic solvent.
4. Chlorhexidine based organic complex of claim 1 wherein ketonic solvent is selected from a group of methyl ethyl ketone, acteophenone , acetone, preferably low boiling alkyl ketones.
5. Chlorhexidine based organic complex of claim 1 wherein , Chlorhexidine based organic complex of claim 1 wherein , organic complex has negligible oral toxicity.
6. Chlorhexidine based organic complex of claim 1 wherein , organic complex has negligible dermal toxicity .
7. Chlorhexidine based organic complex of claims 1 and 6 wherein , organic complex has antimicrobial efficacy for the hand wash.
8. Chlorhexidine based organic complex of claims 1 and 5 wherein , the organic complex is useful in oral health, dental care.
9. Chlorhexidine based organic complex of claim 1 wherein, the organic complex is useful in hair care, skin care formulations.
10. Chlorhexidine based organic complex of claims 1 and 9 wherein, hair care formulations comprise, hair oil, hair creams shampoo, antidandruff applications.
11. Chlorhexidine based organic complex of claims 1,6 and 9 wherein, skin care formulations comprise powders, sun screens, lotions, lipsticks and the like.
12. Chlorhexidine based organic complex of claim 1 wherein the organic complex is used in disinfectants in pharmaceutical disinfectant for instruments, hand washes.
13. Chlorhexidine based organic complex of claim 1 wherein the organic complex is used as antifungal and antifouling agent in Paints , coatings.
14. Chlorhexidine based organic complex of claim 1 wherein the organic complex has antimicrobial activity against gram positive, gram negative bacteria , yeast, mold, fungi.

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 201621005039-Covering Letter [29-06-2021(online)].pdf 2021-06-29
1 FORM28 [12-02-2016(online)].pdf 2016-02-12
2 EVIDENCE FOR SSI [12-02-2016(online)].pdf 2016-02-12
2 201621005039-PETITION u-r 6(6) [29-06-2021(online)].pdf 2021-06-29
3 Drawing [12-02-2016(online)].pdf 2016-02-12
3 201621005039-RELEVANT DOCUMENTS [31-03-2020(online)].pdf 2020-03-31
4 Description(Provisional) [12-02-2016(online)].pdf 2016-02-12
4 201621005039-IntimationOfGrant21-11-2019.pdf 2019-11-21
5 201621005039-POWER OF ATTORNEY-(01-03-2016).pdf 2016-03-01
5 201621005039-PatentCertificate21-11-2019.pdf 2019-11-21
6 201621005039-Response to office action (Mandatory) [06-11-2019(online)].pdf 2019-11-06
6 201621005039-FORM 1-(01-03-2016).pdf 2016-03-01
7 201621005039-ExtendedHearingNoticeLetter-(DateOfHearing-29-10-2019).pdf 2019-10-21
7 201621005039-CORRESPONDENCE-(01-03-2016).pdf 2016-03-01
8 Form 18 [06-07-2016(online)].pdf 2016-07-06
8 201621005039-Correspondence to notify the Controller (Mandatory) [18-10-2019(online)].pdf 2019-10-18
9 Drawing [06-07-2016(online)].jpg 2016-07-06
9 201621005039-HearingNoticeLetter-(DateOfHearing-21-10-2019).pdf 2019-10-01
10 201621005039-ORIGINAL UR 6(1A) FORM 1 & FORM 5-140319.pdf 2019-06-26
10 Description(Complete) [06-07-2016(online)].pdf 2016-07-06
11 201621005039-ABSTRACT [11-03-2019(online)].pdf 2019-03-11
11 FORM28 [21-09-2016(online)].pdf 2016-09-21
12 201621005039-CLAIMS [11-03-2019(online)].pdf 2019-03-11
12 Form 3 [05-10-2016(online)].pdf 2016-10-05
13 201621005039-COMPLETE SPECIFICATION [11-03-2019(online)].pdf 2019-03-11
13 201621005039-CORRESPONDENCE(IPO)-(CERTIFIED)-(22-12-2016).pdf 2016-12-22
14 201621005039-CORRESPONDENCE [11-03-2019(online)].pdf 2019-03-11
14 Form 26 [27-04-2017(online)].pdf 2017-04-27
15 201621005039-DRAWING [11-03-2019(online)].pdf 2019-03-11
15 201621005039-ORIGINAL UNDER RULE 6 (1A)-28-04-2017.pdf 2017-04-28
16 201621005039-FER_SER_REPLY [11-03-2019(online)].pdf 2019-03-11
16 FORM28 [29-04-2017(online)].pdf 2017-04-29
17 201621005039-FORM 3 [11-03-2019(online)].pdf 2019-03-11
17 EVIDENCE FOR SSI [29-04-2017(online)].pdf 2017-04-29
18 201621005039-OTHERS [11-03-2019(online)].pdf 2019-03-11
18 REQUEST FOR CERTIFIED COPY [30-04-2017(online)].pdf 2017-04-30
19 FORM28 [30-04-2017(online)].pdf 2017-04-30
19 201621005039-ENDORSEMENT BY INVENTORS [09-03-2019(online)].pdf 2019-03-09
20 201621005039-FORM-8 [21-10-2017(online)].pdf 2017-10-21
20 201621005039-ORIGINAL UR 6(1A) FORM 3-170918.pdf 2019-01-03
21 201621005039-FER.pdf 2018-09-18
21 201621005039-FORM 3 [05-03-2018(online)].pdf 2018-03-05
22 201621005039-FORM 3 [14-09-2018(online)].pdf 2018-09-14
22 Form-2(Online).pdf 2018-08-11
23 201621005039-ORIGINAL UNDER RULE 6 (1A)-301017.pdf 2018-08-11
24 201621005039-FORM 3 [14-09-2018(online)].pdf 2018-09-14
24 Form-2(Online).pdf 2018-08-11
25 201621005039-FORM 3 [05-03-2018(online)].pdf 2018-03-05
25 201621005039-FER.pdf 2018-09-18
26 201621005039-ORIGINAL UR 6(1A) FORM 3-170918.pdf 2019-01-03
26 201621005039-FORM-8 [21-10-2017(online)].pdf 2017-10-21
27 201621005039-ENDORSEMENT BY INVENTORS [09-03-2019(online)].pdf 2019-03-09
27 FORM28 [30-04-2017(online)].pdf 2017-04-30
28 201621005039-OTHERS [11-03-2019(online)].pdf 2019-03-11
28 REQUEST FOR CERTIFIED COPY [30-04-2017(online)].pdf 2017-04-30
29 201621005039-FORM 3 [11-03-2019(online)].pdf 2019-03-11
29 EVIDENCE FOR SSI [29-04-2017(online)].pdf 2017-04-29
30 201621005039-FER_SER_REPLY [11-03-2019(online)].pdf 2019-03-11
30 FORM28 [29-04-2017(online)].pdf 2017-04-29
31 201621005039-DRAWING [11-03-2019(online)].pdf 2019-03-11
31 201621005039-ORIGINAL UNDER RULE 6 (1A)-28-04-2017.pdf 2017-04-28
32 201621005039-CORRESPONDENCE [11-03-2019(online)].pdf 2019-03-11
32 Form 26 [27-04-2017(online)].pdf 2017-04-27
33 201621005039-COMPLETE SPECIFICATION [11-03-2019(online)].pdf 2019-03-11
33 201621005039-CORRESPONDENCE(IPO)-(CERTIFIED)-(22-12-2016).pdf 2016-12-22
34 201621005039-CLAIMS [11-03-2019(online)].pdf 2019-03-11
34 Form 3 [05-10-2016(online)].pdf 2016-10-05
35 201621005039-ABSTRACT [11-03-2019(online)].pdf 2019-03-11
35 FORM28 [21-09-2016(online)].pdf 2016-09-21
36 201621005039-ORIGINAL UR 6(1A) FORM 1 & FORM 5-140319.pdf 2019-06-26
36 Description(Complete) [06-07-2016(online)].pdf 2016-07-06
37 Drawing [06-07-2016(online)].jpg 2016-07-06
37 201621005039-HearingNoticeLetter-(DateOfHearing-21-10-2019).pdf 2019-10-01
38 Form 18 [06-07-2016(online)].pdf 2016-07-06
38 201621005039-Correspondence to notify the Controller (Mandatory) [18-10-2019(online)].pdf 2019-10-18
39 201621005039-ExtendedHearingNoticeLetter-(DateOfHearing-29-10-2019).pdf 2019-10-21
39 201621005039-CORRESPONDENCE-(01-03-2016).pdf 2016-03-01
40 201621005039-Response to office action (Mandatory) [06-11-2019(online)].pdf 2019-11-06
40 201621005039-FORM 1-(01-03-2016).pdf 2016-03-01
41 201621005039-POWER OF ATTORNEY-(01-03-2016).pdf 2016-03-01
41 201621005039-PatentCertificate21-11-2019.pdf 2019-11-21
42 Description(Provisional) [12-02-2016(online)].pdf 2016-02-12
42 201621005039-IntimationOfGrant21-11-2019.pdf 2019-11-21
43 201621005039-RELEVANT DOCUMENTS [31-03-2020(online)].pdf 2020-03-31
44 201621005039-PETITION u-r 6(6) [29-06-2021(online)].pdf 2021-06-29
44 EVIDENCE FOR SSI [12-02-2016(online)].pdf 2016-02-12
45 201621005039-Covering Letter [29-06-2021(online)].pdf 2021-06-29
45 FORM28 [12-02-2016(online)].pdf 2016-02-12

Search Strategy

1 search_11-09-2018.pdf

ERegister / Renewals

3rd: 27 Nov 2019

From 12/02/2018 - To 12/02/2019

4th: 27 Nov 2019

From 12/02/2019 - To 12/02/2020

5th: 27 Nov 2019

From 12/02/2020 - To 12/02/2021

6th: 09 Jun 2021

From 12/02/2021 - To 12/02/2022

7th: 17 Feb 2022

From 12/02/2022 - To 12/02/2023

8th: 06 Feb 2023

From 12/02/2023 - To 12/02/2024

9th: 26 Jan 2024

From 12/02/2024 - To 12/02/2025

10th: 26 Jan 2024

From 12/02/2025 - To 12/02/2026